AG
AMED

Aperio Group’s Amedisys AMED Stock Holding History

Aperio Group’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$8.39M Buy
28,596
+1,447
+5% +$371K 0.02% 625
2020
Q3 		$6.42M Sell
27,149
-1,662
-6% -$378K 0.02% 652
2020
Q2 		$5.72M Sell
28,811
-3,303
-10% -$616K 0.02% 683
2020
Q1 		$5.89M Buy
32,114
+8,400
+35% +$1.49M 0.03% 594
2019
Q4 		$3.96M Buy
23,714
+2,745
+13% +$408K 0.01% 829
2019
Q3 		$2.75M Sell
20,969
-3,423
-14% -$446K 0.01% 921
2019
Q2 		$2.96M Sell
24,392
-5,334
-18% -$633K 0.01% 901
2019
Q1 		$3.66M Buy
29,726
+7,997
+37% +$1M 0.02% 800
2018
Q4 		$2.54M Buy
21,729
+3,170
+17% +$374K 0.01% 883
2018
Q3 		$2.32M Buy
18,559
+480
+3% +$53K 0.01% 989
2018
Q2 		$1.54M Buy
18,079
+882
+5% +$64.8K 0.01% 1149
2018
Q1 		$1.04M Buy
17,197
+245
+1% +$14K 0.01% 1291
2017
Q4 		$894K Sell
16,952
-417
-2% -$22K ﹤0.01% 1367
2017
Q3 		$972K Sell
17,369
-4,699
-21% -$249K 0.01% 1283
2017
Q2 		$1.39M Buy
22,068
+8,694
+65% +$506K 0.01% 1074
2017
Q1 		$683K Buy
13,374
+1,502
+13% +$71.6K ﹤0.01% 1371
2016
Q4 		$506K Sell
11,872
-99
-0.8% -$4.21K ﹤0.01% 1508
2016
Q3 		$568K Buy
11,971
+409
+4% +$20.4K ﹤0.01% 1375
2016
Q2 		$584K Sell
11,562
-4,372
-27% -$221K ﹤0.01% 1305
2016
Q1 		$770K Buy
15,934
+1,363
+9% +$52.6K 0.01% 1159
2015
Q4 		$573K Buy
14,571
+709
+5% +$28.4K 0.01% 1263
2015
Q3 		$526K Buy
13,862
+178
+1% +$7.51K 0.01% 1271
2015
Q2 		$544K Buy
13,684
+4,636
+51% +$144K 0.01% 1270
2015
Q1 		$242K Buy
9,048
+18
+0.2% +$508 ﹤0.01% 1703
2014
Q4 		$265K Buy
+9,030
New +$223K ﹤0.01% 1587

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Aperio Group's AMED Position: Q4 2020 in Review

Aperio Group increased its Amedisys (AMED) stake by 5.3% in Q4 2020, buying an estimated $371K and bringing the position to 28,596 shares worth $8.39M. The position accounts for 0.02% of the portfolio, ranked #625.

Aperio Group first reported a position in AMED in Q4 2014 and has held it in 25 quarters since. 397 funds tracked by Wall St. Rank hold AMED as of Q4 2020.

  • Aperio Group held 28,596 shares of Amedisys worth $8.39M as of Q4 2020.
  • Aperio Group bought 1,447 Amedisys shares in Q4 2020, an estimated $371K.
  • Amedisys made up 0.02% of Aperio Group's portfolio in Q4 2020, its #625 holding.
  • Aperio Group first reported a position in Amedisys in Q4 2014 and has held it in 25 quarters since.
  • 397 funds tracked by Wall St. Rank held Amedisys as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.